ASCL2 and autoimmune disease: This and future studies are likely to reveal ASCL2-regulated pathways vital for immunoregulatory functions of NK cells that can be targeted to circumvent NK cell suppression of vaccine response or to bolster NK-cell based therapies targeting pathogenic T and B cells in autoimmune disease.